Chesapeake Asset Management LLC Stryker Corp Transaction History

Chesapeake Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Jan 05, 2026	SELL	$355.18 - $399.9 $355 - $399	-1 Reduced 25.0%	3 $1.12 Million
Q4 2024 Jan 05, 2026	SELL	$345.14 - $392.15 $2,070 - $2,352	-6 Reduced 60.0%	4 $1.44 Million
Q3 2024 Jan 05, 2026	BUY	$315.94 - $371.96 $947 - $1,115	3 Added 42.86%	10 $3.61 Million
Q2 2024 Jan 05, 2026	BUY	$324.3 - $354.67 $2,270 - $2,482	7 New	7 $2.38 Million
Q3 2023 Jan 05, 2026	BUY	$266.54 - $302.43 $1,865 - $2,117	7 New	7 $1.91 Million

Q2 2023 Jan 05, 2026	SELL	$271.49 - $305.09 $14,660 - $16,474	-54 Closed	0 $0
Q1 2023 Jan 05, 2026	BUY	$246.13 - $285.47 $13,291 - $15,415	54 New	54 $15.4 Million

2,586

296M

1.22M

948K

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Asset Management LLC with notifications on news.